CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 120 enrolled
Drug / intervention
Assessing the impact of COVID-19other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04474496
NCT04474496N/ACompleted

Impact of COVID-19 on Marshallese Communities in the U.S.

University of Arkansas·observational·Posted Jul 16, 2020·Updated Apr 5, 2021

In Brief

An observational study evaluating Assessing the impact of COVID-19 for COVID-19. Completed, enrolled 120 participants across 1 site.

Detailed Summary

Marshallese adults in the U.S. will complete an online or telephone survey. This survey will collect data describing the impact of COVID-19 on Marshallese communities. Data collected will help describe: 1) risk exposure, 2) knowledge of preventive recommendations, 3) barriers and facilitators to implementing preventative recommendations, 4) barriers and facilitators to COVID-19 testing when appropriate, and 5) self-care behaviors during COVID-19. Participant inclusion criteria: 1) Self-reported Marshallese; 2) 18 years of age or older; 3) Live in the Continental U.S. or Hawaii.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJul 16, 2020
Enrollment StartJul 27, 2020
Primary CompletionNov 30, 2020
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 6.0 years ago

Interventions

Assessing the impact of COVID-19other

Surveying Marshallese adults in the U.S. to determine the impact of COVID-19